These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14522263)

  • 1. Tryptophan depletion and HIV infection: a metabolic link to pathogenesis.
    Murray MF
    Lancet Infect Dis; 2003 Oct; 3(10):644-52. PubMed ID: 14522263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide.
    Murray MF; Langan M; MacGregor RR
    Nutrition; 2001; 17(7-8):654-6. PubMed ID: 11448590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
    Bipath P; Levay PF; Viljoen M
    BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
    Neurauter G; Zangerle R; Widner B; Quirchmair G; Sarcletti M; Fuchs D
    Adv Exp Med Biol; 2003; 527():317-23. PubMed ID: 15206745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oxidative stress-induced niacin sink (OSINS) model for HIV pathogenesis.
    Taylor EW
    Toxicology; 2010 Nov; 278(1):124-30. PubMed ID: 19857540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy.
    Fuchs D; Gisslén M; Larsson M; Norkrans G; Hagberg L; Wachter H
    Adv Exp Med Biol; 1996; 398():131-4. PubMed ID: 8906255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma ratio of tryptophan to competing large neutral amino acids in human immunodeficiency virus type 1 infected subjects: possible implications for development of neuro-psychiatric disorders.
    Eriksson T; Lidberg L
    J Neural Transm (Vienna); 1996; 103(1-2):157-64. PubMed ID: 9026369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease.
    Look MP; Altfeld M; Kreuzer KA; Riezler R; Stabler SP; Allen RH; Sauerbruch T; Rockstroh JK
    AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1215-21. PubMed ID: 10957719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additive effect of type 2 diabetes on fibrinogen, von Willebrand factor, tryptophan and threonine in people living with HIV.
    Harrison ML; Wolfe AS; Fordyce J; Rock J; García AA; Zuñiga JA
    Amino Acids; 2019 May; 51(5):783-793. PubMed ID: 30868261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.
    Fuchs D; Möller AA; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
    Immunol Lett; 1991 Jun; 28(3):207-11. PubMed ID: 1909303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution.
    Yap SH; Abdullah NK; McStea M; Takayama K; Chong ML; Crisci E; Larsson M; Azwa I; Kamarulzaman A; Leong KH; Woo YL; Rajasuriar R
    PLoS One; 2017; 12(10):e0186000. PubMed ID: 29016635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma amino acid concentrations in response to HIV-1 infection.
    Hortin GL; Landt M; Powderly WG
    Clin Chem; 1994 May; 40(5):785-9. PubMed ID: 7909726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of L-lysine amino acid on the HIV-1 RNA replication in vitro.
    Butorov EV
    Antivir Chem Chemother; 2015 Feb; 24(1):39-46. PubMed ID: 26149265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy.
    Lee S; Byakwaga H; Boum Y; Burdo TH; Williams KC; Lederman MM; Huang Y; Tracy RP; Cao H; Haberer JE; Kembabazi A; Bangsberg DR; Martin JN; Hunt PW
    J Infect Dis; 2017 Apr; 215(8):1270-1274. PubMed ID: 28329310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
    Valle M; Price RW; Nilsson A; Heyes M; Verotta D
    Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and immune activation in patients with HIV-infection.
    Schroecksnadel K; Sarcletti M; Winkler C; Mumelter B; Weiss G; Fuchs D; Kemmler G; Zangerle R
    Brain Behav Immun; 2008 Aug; 22(6):881-9. PubMed ID: 18261883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease.
    Penberthy WT
    Curr Drug Metab; 2007 Apr; 8(3):245-66. PubMed ID: 17430113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan catabolism and immune activation in primary and chronic HIV infection.
    Gelpi M; Hartling HJ; Ueland PM; Ullum H; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 May; 17(1):349. PubMed ID: 28511640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune activation and decreased tryptophan in patients with HIV-1 infection.
    Fuchs D; Forsman A; Hagberg L; Larsson M; Norkrans G; Reibnegger G; Werner ER; Wachter H
    J Interferon Res; 1990 Dec; 10(6):599-603. PubMed ID: 2128302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.